The European Commission (EC) has granted marketing authorisation for AstraZeneca's new four-in-one influenza vaccine Fluenz Tetra for the prevention of influenza in children and adolescents from 24 months up to 18 years of age. The ...
Tags: Chronic Hepatitis, Medicine
British drugmaker AstraZeneca has received positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) for its new four-in-one flu vaccine Fluenz Tetra. Fluenz Tetra, a nasally ...
Tags: Astrazeneca, Medicine
A 5 year $5.4m grant has been awarded to Profectus BioSciences and the Galveston National Laboratory (GNL) at the University of Texas Medical Branch at Galveston to support the development of a Vesicular Stomatitis virus-vectored vaccine ...
Tags: Trivalent Vaccine, rVSV-vectored filovirus, Ebola and Marburg Viruses